COMMONWEALTH EQUITY SERVICES, LLC

Position in VYGR — Voyager Therapeutics, Inc.

CIK 312272 WALTHAM, MA

Position in VYGR

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$43,633

-$595 QoQ

Shares Held

11,304

+0.4% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

13 quarters on record

Healthcare · as of Mar 31, 2026

COMMONWEALTH EQUITY SERVICES, LLC holds $113,232,394 across 120 Biotechnology names. VYGR ranks #97 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	54,972	$24,547,196
2	REGN	Regeneron Pharmaceuticals, Inc.	16,385	$12,659,706
3	EXEL	Exelixis, Inc.	173,762	$7,452,652
4	TGTX	Tg Therapeutics, Inc.	180,285	$5,989,067
5	TARS	Tarsus Pharmaceuticals, Inc.	80,892	$5,674,573
6	CRSP	CRISPR Therapeutics AG	78,488	$3,733,674
7	ALNY	Alnylam Pharmaceuticals, Inc.	10,577	$3,499,611
8	ARWR	Arrowhead Pharmaceuticals, Inc.	55,076	$3,453,265

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$43,633	11,304	+0.4%	Shares	Sole	2026-04-27
2025-12-31	$44,228	11,254	-31.7%	Shares	Sole	2026-02-12
2025-09-30	$76,947	16,477	-54.2%	Shares	Sole	2025-10-22
2025-06-30	$111,804	35,950	-46.6%	Shares	Sole	2025-08-06
2025-03-31	$227,555	67,324	+2.0%	Shares	Sole	2025-05-09
2024-12-31	$374,390	66,030	-4.2%	Shares	Sole	2025-02-10
2024-09-30	$403,240	68,930	-11.5%	Shares	Sole	2024-10-18
2024-06-30	$616,228	77,905	+36.8%	Shares	Sole	2024-07-31
2024-03-31	$530,251	56,955	+216.4%	Shares	Sole	2024-04-29
2023-03-31	$138,780	18,000	-23.4%	Shares	Sole	2023-05-11
2022-12-31	$143,350	23,500	-3.4%	Shares	Sole	2023-02-07
2022-09-30	$144,057	24,334	0.0%	Shares	Sole	2022-11-14
2022-06-30	$143,813	24,334	—	Shares	Sole	2022-07-19
No filing history on record for this holder in this stock.